Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Resolution · 119th Congress · HRES 685

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Refreshed 6 h ago

Introduced 2025-09-09Topic: health care · public health

Summary

AI-generated summary, report an error

This resolution states that the House of Representatives supports testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening. APS is a condition in which the immune system makes antibodies that raise the risk of blood clots and pregnancy loss. The resolution notes that medical groups currently recommend APS testing only after certain unexplained pregnancy losses. It calls on professional medical associations and guideline-setting bodies to update their recommendations to include APS testing in standard prenatal screening. The resolution does not create a legal requirement or provide funding.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2025-09-09HouseReferred to the House Committee on Energy and Commerce.refer
2025-09-09Submitted in Houserefer
2025-09-09Submitted in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.